# Title
Propionyl-L-carnitine B-Chemical
improves O
postischemic O
blood O
flow O
recovery O
and O
arteriogenetic O
revascularization O
and O
reduces O
endothelial O
NADPH-oxidase O
4-mediated O
superoxide B-Chemical
production. O

# Abstract
OBJECTIVE: O
The O
beneficial O
effect O
of O
the O
natural O
compound O
propionyl-l-carnitine B-Chemical
(PLC) B-Chemical
on O
intermittent B-Disease
claudication I-Disease
in O
patients B-Species
with O
peripheral B-Disease
arterial I-Disease
disease I-Disease
is O
attributed O
to O
its O
anaplerotic O
function O
in O
ischemic B-Disease
tissues, O
but O
inadequate O
information O
is O
available O
concerning O
action O
on O
the O
vasculature. O
METHODS O
AND O
RESULTS: O
We O
investigated O
the O
effects O
of O
PLC B-Chemical
in O
rabbit B-Species
hind O
limb O
collateral O
vessels O
after O
femoral O
artery O
excision, O
mouse B-Species
dorsal O
air O
pouch, O
chicken B-Species
chorioallantoic O
membrane, O
and O
vascular O
cells O
by O
angiographic, O
Doppler O
flow, O
and O
histomorphometrical O
and O
biomolecular O
analyses. O
PLC B-Chemical
injection O
accelerated O
hind O
limb O
blood O
flow O
recovery O
after O
4 O
days O
(P<0.05) O
and O
increased O
angiographic O
quadriceps O
collateral O
vascularization O
after O
7 O
days O
(P<0.001) O
Histomorphometry O
confirmed O
the O
increased O
vascular O
area O
(P<0.05), O
with O
unchanged O
intramuscular O
capillary O
density. O
PLC-induced O
dilatative O
adaptation, O
and O
growth O
was O
found O
associated O
with O
increased O
inducible O
nitric O
oxide O
synthase O
and O
reduced O
arterial O
vascular B-Gene
endothelial I-Gene
growth I-Gene
factor I-Gene
and O
intracellular O
adhesion O
molecule-1 O
expression. O
PLC B-Chemical
also O
increased O
vascularization O
in O
air O
pouch O
and O
chorioallantoic O
membrane O
(P<0.05), O
particularly O
in O
large O
vessels. O
PLC B-Chemical
increased O
endothelial O
and O
human B-Species
umbilical O
vascular O
endothelial O
cell O
proliferation O
and O
rapidly O
reduced O
inducible O
nitric O
oxide O
synthase O
and O
NADPH-oxidase O
4-mediated O
reactive B-Chemical
oxygen I-Chemical
species I-Chemical
production O
in O
human B-Species
umbilical O
vascular O
endothelial O
cells; O
NADPH-oxidase B-Gene
4 I-Gene
also O
regulated O
NF-kappaB-independent O
intracellular O
adhesion O
molecule-1 O
expression. O
CONCLUSIONS: O
Our O
results O
provided O
strong O
evidence O
that O
PLC B-Chemical
improves O
postischemic O
flow O
recovery O
and O
revascularization O
and O
reduces O
endothelial O
NADPH-oxidase-related O
superoxide B-Chemical
production. O
We O
recommend O
that O
PLC B-Chemical
should O
be O
included O
among O
therapeutic O
interventions O
that O
target O
endothelial O
function. O